ReviewCurrent cardiology reports2018
Short- and Long-term Mortality Risk After Acute Pulmonary Embolism.
Review in Current cardiology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Thrombolytic therapy for pulmonary embolism.The Cochrane database of systematic reviews · 2021Pooled it
- Thrombolytic therapy for pulmonary embolism.The Cochrane database of systematic reviews · 2018Pooled it
- Diagnostic performance of lung perfusion SPECT/CT using perfusion defect and decrease criteria: a comparative study with CTPA in pulmonary thromboembolism.Annals of nuclear medicine · 2026Article
- Comorbidity characteristics and impact in patients with acute pulmonary thromboembolism: a retrospective study.BMC pulmonary medicine · 2025Article
- Long-term in-hospital mortality and chronic thromboembolic pulmonary hypertension after COVID-19-associated pulmonary embolism in France: a nationwide study.ERJ open research · 2025Article
- Development of a predictive nomogram for early identification of pulmonary embolism in hospitalized patients: a retrospective cohort study.BMC pulmonary medicine · 2024Article
- Short-term mortality prediction in acute pulmonary embolism: Radiomics values of skeletal muscle and intramuscular adipose tissue.Journal of cachexia, sarcopenia and muscle · 2024Article
- Short- and Long-Term Mortality for Patients With and Without a Cancer Diagnosis Following Pulmonary Embolism in Denmark, 2000 to 2020: A Nationwide Study.Journal of the American Heart Association · 2023Article
- Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.Pharmacology · 2023Article
- Reply to letter to the editor: ''Predicting long-term mortality after acute pulmonary embolism: One issue, multiple faces''.Anatolian journal of cardiology · 2022Article
- Hyponatremia-Long-Term Prognostic Factor for Nonfatal Pulmonary Embolism.Diagnostics (Basel, Switzerland) · 2021Article
- The assessment of acute pulmonary embolism severity using CT angiography features.International journal of emergency medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewAcute pulmonary embolism is a major cause of morbidity and mortality in the USA and throughout the world. This review will summarize recent developments in short- and long-term mortality risk assessment after an acute pulmonary embolism. RECENT
findingsRecent guidelines have emphasized risk stratification of acute PE patients on the basis of blood pressure, right ventricular size, and biomarker status. Ongoing work is testing various acute treatment strategies for improvement of symptom burden, length of stay, quality of life, and possibly mortality risk reduction. Long-term outcomes among subjects with acute PE are less well studied. Long-term mortality largely correlates with baseline co-morbidity burden, although there may be an association between acute PE severity and long-term outcomes. Acute PE risk stratification and treatment, as well as long-term follow-up of patients with acute PE, are rapidly developing areas and many promising innovations are underway.
Indexed as
Identifiers
30311090What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.